Radiofrequency electromagnetic field treatment

DEVICE3 trials

Sponsors

Charite University, Berlin, Germany

Conditions

GlioblastomaHepatocellular Carcinoma (HCC)Refractory Metastatic Colorectal Cancer

Unknown Phase

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Refractory Metastatic Colorectal Cancer

RecruitingNCT05991102

Charite University, Berlin, GermanyRefractory Metastatic Colorectal Cancer

Start: 2023-12-15End: 2026-11-30Target: 12Updated: 2023-12-21

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

RecruitingNCT06140875

Charite University, Berlin, GermanyGlioblastoma

Start: 2023-11-15End: 2029-05-14Target: 26Updated: 2025-02-13

Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)

RecruitingNCT06821958

Charite University, Berlin, GermanyHepatocellular Carcinoma (HCC)

Start: 2025-03-01End: 2029-02-28Target: 36Updated: 2025-02-12